Top Rated Pot Stock in the Drug Manufacturers - Specialty Generic Industry Drops -2.78 percent Tuesday Is it Time to Sell SNDL Inc - InvestorsObserver Top Rated Pot Stock in the Drug Manufacturers - Specialty Generic Industry Drops -2.78 percent Tuesday Is it Time to Sell SNDL Inc InvestorsObserver

Top Rated Pot Stock in the Drug Manufacturers - Specialty Generic Industry Drops -2.78 percent Tuesday Is it Time to Sell SNDL Inc - InvestorsObserver

ATHE Stock  USD 4.64  0.29  6.67%   
About 56% of all Alterity Therapeutics' shareholders are looking to take a long position. The analysis of the overall investor sentiment regarding Alterity Therapeutics suggests that some traders are interested. The current market sentiment, together with Alterity Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Alterity Therapeutics stock news signals to limit their universe of possible portfolio assets.
Top Rated Pot Stock in the Drug Manufacturers - Specialty Generic Industry Drops -2.78 percent Tuesday Is it Time to Sell SNDL Inc InvestorsObserver

Read at news.google.com
Google News at Macroaxis
  

Alterity Therapeutics Fundamental Analysis

We analyze Alterity Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alterity Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alterity Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Beta

Beta Comparative Analysis

Alterity Therapeutics is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Alterity Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alterity Therapeutics stock to make a market-neutral strategy. Peer analysis of Alterity Therapeutics could also be used in its relative valuation, which is a method of valuing Alterity Therapeutics by comparing valuation metrics with similar companies.

Peers

Alterity Therapeutics Related Equities

SRZNSurrozen   7.48   
0%
100.0%
RVPHReviva Pharmaceuticals   1.82   
0%
24.0%
ADILAdial Pharmaceuticals   1.47   
0%
19.0%
RNAZTranscode Therapeutics   1.46   
0%
19.0%
ARTLArtelo Biosciences   1.00   
0%
13.0%
HCWBHCW Biologics   0.25   
0%
3.0%
MNPRMonopar Therapeutics   0.22   
2.0%
0%
ADTXAditxt   0.59   
7.0%
0%
TARAProtara Therapeutics   0.63   
8.0%
0%
PMVPPmv Pharmaceuticals   1.10   
14.0%
0%
NBYNovaBay Pharmaceuticals   1.79   
23.0%
0%
ANTXAN2 Therapeutics   2.54   
33.0%
0%
ANEBAnebulo Pharmaceuticals   2.78   
37.0%
0%
QNRXQuoin Pharmaceuticals   3.20   
42.0%
0%

Complementary Tools for Alterity Stock analysis

When running Alterity Therapeutics' price analysis, check to measure Alterity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alterity Therapeutics is operating at the current time. Most of Alterity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Alterity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alterity Therapeutics' price. Additionally, you may evaluate how the addition of Alterity Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Bonds Directory
Find actively traded corporate debentures issued by US companies
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
CEOs Directory
Screen CEOs from public companies around the world
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm